SAT0099 Polypharmacy is associated with an increased risk of adverse outcomes in patients with rheumatoid arthritis
Sign Up to like & getrecommendations! Published in 2017 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2017-eular.2262
Abstract: Background In the general population, polypharmacy (PP) is associated with increased risk of adverse events. The relationship between adverse outcomes and PP in Rheumatoid Arthritis (RA) has not been studied in depth. The mantra of… read more here.
Keywords: polypharmacy associated; adverse outcomes; relationship; associated increased ... See more keywords